KEYNOTE-426 Axitinib plus pembrolizumab vs sunitinib in the first-line treatment of metastatic renal cell carcinoma-MedSci.cn

KEYNOTE-426 Axitinib plus pembrolizumab vs sunitinib in the first-line treatment of metastatic renal cell carcinoma

Bedke, J; Stuhler, V

Bedke, J (corresponding author), Eberhard Karls Univ Tubingen, Klin Urol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.

UROLOGE, 2020; 59 (7): 841

科室
- - 订阅+
  - 更多科室
工具
服务